/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study
Event: ESC Congress 2024
Topic: Drug therapy
Session: Dyslipidaemia: novel diagnostics and therapy options
Impact of antihypertensive medication regimens on blood pressure control in individuals with established coronary heart disease
Event: ESC Congress 2022
Topic: Secondary Prevention
Session: Secondary prevention 2
Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease
Event: ESC Preventive Cardiology 2022
Topic: Secondary Prevention
Session: ePosters
The demographic, psychosocial and clinical characteristics associated with cardiac risk factor control: an analysis of secondary prevention in adults with established coronary heart disease
Event: ESC Preventive Cardiology 2022
Topic: Secondary Prevention
Session: ePosters
